Associate Director, Biostatistician

Madrigal Pharmaceuticals focuses on novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease. Rezdiffra (resmetirom) is the first FDA and European Commission approved medication for MASH with moderate to advanced fibrosis. The Associate Director of Biostatistics independently leads biostatistical activities for studies across clinical development phases.

This role translates organizational objectives into statistical deliverables and drives execution of statistical strategies. The Associate Director performs and reviews complex statistical analyses while contributing to protocol development and Statistical Analysis Plans. Serves as the statistical point of contact for study teams.

Coordinates with biostatisticians, programmers, and cross-functional members including clinical research, medical affairs, and data management. Works with internal teams or CRO partners using clinical data structures like SDTM/ADaM. Reports to the VP of Biostatistics & Data Science.

Builds a dynamic, inclusive culture valuing scientific excellence, operational rigor, and collaboration. Contributes to evidence generation from trials and real-world data. Supports ongoing growth in a high-performing biotech environment.